Abstract
AbstractWe demonstrate excitation of photosensitisers (PSs) by accelerated protons to produce fluorescence and singlet oxygen. Their fluorescence follows a pattern similar to the proton energy loss in matter, while proton-derived fluorescence spectra match the photon-induced spectra. PSs excited in dry gelatin exhibit enhanced phosphorescence, suggesting an efficient PSs triplet state population. Singlet oxygen measurements, both optically at ~1270 nm and through the photoproduct of protoporphyrin IX (PpIX), demonstrate cytotoxic singlet oxygen generation by proton excitation. The singlet oxygen-specific scavenger 1,4-diazabicyclo[2.2.2]octane (DABCO) abrogates the photoproduct formation under proton excitation, but cannot countermand the overall loss of PpIX fluorescence. Furthermore, in two cell lines, M059K and T98G, we observe differential cell death upon the addition of the PS cercosporin, while in U87 cells we see no effect at any proton irradiation dose. Our results pave the way for a novel treatment combining proton therapy and “proton-dynamic therapy” for more efficient tumour eradication.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference27 articles.
1. Macrobert, A. J. & Theodossiou, T. in Encyclopedia of Modern Optics Vol. 1 (ed R. D. Guenther) p. 53–62 (Elsevier, Amsterdam, 2005).
2. Agostinis, P. et al. Photodynamic therapy of cancer: an update. CA: a cancer J. Clin. 61, 250–281 (2011).
3. Dougherty, T. J. et al. Photodynamic therapy. J. Natl. Cancer Inst. 90, 889–905 (1998).
4. Dolmans, D. E., Fukumura, D. & Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. 3, 380–387 (2003).
5. Fuchs, J. & Thiele, J. The role of oxygen in cutaneous photodynamic therapy. Free Radic. Biol. Med. 24, 835–847 (1998).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献